Alcyone is committed to developing biologically inspired and clinically relevant patient solutions. These solutions are meant to significantly enhance current treatments for patients with chronic neuropathological conditions.
PJ Anand discusses Alcyone’s work in creating delivery systems for medications that won’t involve administering meds orally or through the bloodstream. The most effective future treatments will be administered directly into the brain or spinal cord. PJ illustrates for us exactly how this can work.